Literature DB >> 7046484

Prognosis in patients with obstructing colorectal carcinoma.

U Ohman.   

Abstract

Over a 30 year interval (1950 to 1979), 1,061 patients with colorectal carcinoma were seen; 148 presented with bowel obstruction and in this retrospective study were compared with those having nonobstructive tumors. The age and sex distribution did not differ between the groups. The curability rate was 53 percent, versus 72 percent for nonobstructed patients; the 5 year survival rate was 16 percent overall and 31 percent in curable cases, versus 37 and 50 percent for elective patients, respectively. Survival within tumor stages did not differ between the groups; the difference in outcome was mainly a result of obstructed patients having fewer stage A and more stage C lesions. Most right-sided growths were primarily resected, while the left-sided growths were mainly treated with staged resection. Operative mortality for curable patients was 8 percent, not different from the 7 percent rate in elective patients. The 5 year survival rate was 19 percent after primary and 35 percent after staged resection. It was concluded that patients with bowel obstruction secondary to colorectal carcinoma have low curability and survival rates, primarily because of advanced disease at the time of diagnosis and treatment.

Entities:  

Mesh:

Year:  1982        PMID: 7046484     DOI: 10.1016/0002-9610(82)90050-2

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  69 in total

1.  Expandable metal stents in malignant colorectal obstruction. Promising, but trials are needed on safety and cost effectiveness.

Authors:  T Ahmad; A S Mee
Journal:  BMJ       Date:  2000-09-09

2.  Which surgeons avoid a stoma in treating left-sided colonic obstruction? Results of a postal questionnaire.

Authors:  N J Carty; A P Corder
Journal:  Ann R Coll Surg Engl       Date:  1992-11       Impact factor: 1.891

3.  Complete single-stage management of left colon cancer obstruction with a new device.

Authors:  J-H Kim; D-H Shon; S-H Kang; B-I Jang; M-K Chung; J-H Kim; M-C Shim
Journal:  Surg Endosc       Date:  2005-07-28       Impact factor: 4.584

4.  Double synchronous occluding tumors of the large bowel: a report of three cases.

Authors:  D Tuscano; L D'Amore; P Negro; M Scaccia; C Talarico; F Gossetti; D Flati; M Carboni
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

5.  Perforated colonic cancer presenting as intra-abdominal abscess.

Authors:  Hsiang-Lin Tsai; Jan-Sing Hsieh; Fang-Jung Yu; Deng-Chyang Wu; Fang-Ming Chen; Che-Jen Huang; Yu-Sheng Huang; Tsung-Jen Huang; Jaw-Yung Wang
Journal:  Int J Colorectal Dis       Date:  2006-04-20       Impact factor: 2.571

Review 6.  Decision making and quality of life in the treatment of cancer: a review.

Authors:  S Yousuf Zafar; Stewart C Alexander; Kevin P Weinfurt; Kevin A Schulman; Amy P Abernethy
Journal:  Support Care Cancer       Date:  2008-09-19       Impact factor: 3.603

7.  Colonic perforation either during or after stent insertion as a bridge to surgery for malignant colorectal obstruction increases the risk of peritoneal seeding.

Authors:  Su Jin Kim; Hyung Wook Kim; Su Bum Park; Dae Hwan Kang; Cheol Woong Choi; Byeong Jun Song; Joung Boom Hong; Dong Jun Kim; Byung Soo Park; Gyung Mo Son
Journal:  Surg Endosc       Date:  2015-02-13       Impact factor: 4.584

Review 8.  Colonic perforation with intraluminal stents and bevacizumab in advanced colorectal cancer: retrospective case series and literature review.

Authors:  Amal Imbulgoda; Anthony MacLean; John Heine; Sebastien Drolet; Michael M Vickers
Journal:  Can J Surg       Date:  2015-06       Impact factor: 2.089

9.  Managing acute colorectal obstruction by "bridge stenting" to laparoscopic surgery: Our experience.

Authors:  Pierfrancesco Bonfante; Luigi D'Ambra; Stefano Berti; Emilio Falco; Massimo Vittorio Cristoni; Romolo Briglia
Journal:  World J Gastrointest Surg       Date:  2012-12-27

10.  Trends in demographics and management of obstructing colorectal cancer.

Authors:  Zaheer Moolla; Thandinkosi E Madiba
Journal:  World J Surg       Date:  2014-09       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.